Results for produktresumeet translation from Danish to English

produktresumeet
the summary of product characteristics

Ændringer til produktresumeet
amendments to the summary of product characteristics

- en kopi af produktresumeet
- a copy of the spc

se produktresumeet for bortezomib.
see the spc for bortezomib.

se produktresumeet for peginterferon alfa.
please refer to the summary of product characteristics for peginterferon alfa.

begrundelse for Ændringen af produktresumeet
grounds for amendment of the summary of product characteristics

for yderligere oplysninger se produktresumeet.
for further details, refer to the spc.

se produktresumeet vedrørende yderligere oplysninger.
please see the summary of product characteristics for more information.

begrundelse for Ændring af produktresumeet/ erne
summary(ies) of

for yderligere oplysninger henvises til produktresumeet.
refer to the smpc for full details.

der henvises til produktresumeet for yderligere information.
please refer to the spc for further details.

vigtigt: du bedes læse produktresumeet før ordinering.
important:please refer to the summary of product characteristics before prescribing.

se produktresumeet til emtriva 10 mg/ml oral opløsning.
please refer to the summary of product characteristics for emtriva 10 mg/ml oral solution.

chmp blev også enige om følgende ændringer til produktresumeet:
the chmp agreed also on the following changes to the spc:

5 begrundelser for Ændring af produktresumeet, etiketteringen og indlÆgssedlen
7 grounds for amendment of the summaries of product characteristics, labelling and package leaflet

se produktresumeet for ribavirin og peginterferon alfa for yderligere information.
refer to summary of product characteristics for ribavirin and peginterferon alfa for additional information.

faglige konklusioner og begrundelser for Ændringen af produktresumeet fremlagt af emea
scientific conclusions and grounds for amendment of the summary of product characteristics presented by the emea

se venligst også produktresumeet (spc) for interferon alfa-2b.25
25 please refer also to the interferon alfa-2b summary of product characteristics (spc) .

behandlingen skal fortsættes med dicural overtrukne tabletter (se produktresumeet).
treatment must then be continued with dicural coated tablets (see that spc).

se produktresumeet for yttrium- 90 for instruktioner vedrørende forberedelse og anvendelse.
refer to summary of product characteristics of yttrium-90 for instructions on preparation and use.